Cidara Therapeutics | 8-K: Current report
Cidara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sandison Taylor
Cidara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Tari Leslie
Cidara Therapeutics | 8-K: Current report
Cidara Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Cidara Therapeutics | 8-K: Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
Cidara Therapeutics | 10-Q: Q2 2024 Earnings Report
Cidara Therapeutics | EFFECT: Others
Cidara Therapeutics | 424B3: Prospectus
Cidara Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BCLS Fund III Investments, LP(9.99%)
Cidara Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Canaan XII L.P.(9.99%),Canaan Partners XII LLC(9.99%)
Cidara Therapeutics | CORRESP: CORRESP
Cidara Therapeutics | UPLOAD: Others
Cidara Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%), etc.
Cidara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
Cidara Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director RA CAPITAL MANAGEMENT, L.P.
Cidara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
Cidara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BURGESS DANIEL D
Cidara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bassler Bonnie L
Cidara Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
No Data
No Data